Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma. [electronic resource]
Producer: 20191213Description: 6635-6643 p. digitalISSN:- 1791-7530
- AMP-Activated Protein Kinases -- antagonists & inhibitors
- Animals
- Apoptosis
- Brain Neoplasms -- metabolism
- CASP8 and FADD-Like Apoptosis Regulating Protein -- metabolism
- Caspase 3 -- metabolism
- Combined Modality Therapy
- Glioblastoma -- metabolism
- Heterografts
- Humans
- Male
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells -- metabolism
- Mice
- Mice, Nude
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Pyrazoles -- therapeutic use
- Pyrimidines -- therapeutic use
- TNF-Related Apoptosis-Inducing Ligand -- metabolism
- X-Linked Inhibitor of Apoptosis Protein -- metabolism
- bcl-2-Associated X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.